Botulism causative agent

Morphology and cultural characteristics

The causative agent of botulism is a motile rod (peritrichous) with rounded ends. In young cultures, the bacteria are Gram-positive, whereas older cultures (by 4–5 days) become Gram-negative. Under unfavorable conditions, the microorganism forms spores. These are located subterminally (near the end of the cell) and exceed the thickness of the bacterium itself in diameter, giving it the characteristic appearance of a "tennis racket".

C. botulinum is an obligate anaerobe, growing exclusively in the absence of oxygen. The optimal cultivation temperature is 28–35 °C. In liquid nutrient media (e.g., Kitt-Tarozzi medium), growth is accompanied by turbidity, intensive gas production, and the appearance of a specific rancid-butter odor (the result of butyric acid fermentation). On solid media, it forms distinct colonies:

• On blood agar, small lens-shaped colonies surrounded by a zone of hemolysis grow.
• In agar deeps, R-forms resemble fluff balls with a dense center, while S-forms appear as lenticular formations.

Pathogenicity factors: botulinum toxin

The primary virulence factor of the microorganism is botulinum exotoxin. Toxins of types A, B, E, and F are pathogenic to humans, with type A considered the most potent. The toxin molecule is a complex protein structure consisting of a biologically active neurotoxin and non-toxic proteins that act as stabilizers.

The exotoxin is thermolabile: at 80 °C it is inactivated within 30 minutes, and it is destroyed by boiling. This property is crucial for sanitary and hygienic prevention of food poisoning. Notably, in microdoses, botulinum toxin is actively used in medicine: in neurology to relieve muscle spasms in cerebral palsy or torticollis, in urology, and in cosmetology to smooth mimic wrinkles.

Epidemiology and pathogenesis

By type of infection, botulism is classified as a sapronosis. The main reservoirs of the pathogen are soil and herbivorous animals (in whose intestines the microbe accumulates). The transmission mechanism is fecal-oral, and the route is alimentary. The disease is most commonly associated with the consumption of foods where anaerobic conditions are created: home-canned vegetables and mushrooms, sausages, and home-smoked fish. It is precisely the absence of air that allows spores to germinate and actively secrete toxin.

Botulism proceeds as a toxemic infection:

1. The exotoxin is absorbed in the stomach and the upper sections of the small intestine.
2. It is carried throughout the body via the bloodstream, reaching target organs.
3. It affects the cholinergic synapses of motor nerves.
4. It causes presynaptic blockade of the release of the neurotransmitter acetylcholine.

As a result, motor neurons of the spinal cord and brainstem are affected, leading to severe paralysis and bulbar disorders.

Clinical presentation and microbiological diagnostics

The incubation period lasts from several hours to 10 days and is inversely proportional to the toxin dose. The initial symptoms are general malaise, headache, and vomiting. A classic early sign is visual impairment (ophthalmoplegic syndrome, double vision). As the disease progresses, speech and swallowing disorders develop. Without treatment, death may occur due to paralysis of the respiratory muscles.

Materials for laboratory examination include blood, vomitus, gastric lavage fluid, urine, and remnants of suspicious food. The primary method for toxin detection is the bioassay in white mice (neutralization test). A mixture of the test material and diagnostic type A, B, E, F sera is injected intraperitoneally into mice. Survival of the animal with a specific antiserum clearly indicates the toxin type. For rapid diagnostics, indirect hemagglutination assay (IHA), ELISA, and direct immunofluorescence assay (DFA) are used.

Principles of treatment and prevention

Post-infection immunity is not established after recovering from botulism, so treatment requires immediate medical intervention.

Specific therapy consists of the administration of botulinum antitoxin to neutralize the toxin. Before the exact toxin type is established, polyvalent serum (containing antibodies against types A, B, and E) is used, and after confirmation, it is switched to monovalent serum. The drug is administered fractionated using the Besredka method to prevent anaphylactic shock. Additionally, etiotropic therapy (antibiotics, e.g., chloramphenicol) is prescribed.

For routine specific prophylaxis in risk groups, tri-toxoid or tetra-toxoid can be used. Non-specific prophylaxis comes down to strict quality control in canned food production and mandatory rejection of swollen cans ("blown cans").

Briefly: answers to topical questions

Class and exam questions

What else to study on this topic

• Detailed classification of the pathogen into 4 groups based on biochemical profile
• Mechanism of action of the neurotoxin at the cellular level in cholinergic synapses
• Thermal and chemical resistance of spores and vegetative forms of the microorganism
• Antigenic structure of the bacterium and serological classification (8 serovars)

Other topics in the section "Gram-positive spore-forming bacilli (Anthrax, Clostridia: tetanus, botulism, gas gangrene, difficile)"

Prepared by WhiteCoat Pro faculty in accordance with the medical school curriculum. For educational purposes only.